It's the second such finding from U.S. health officials in a week...
Demand for the drugs has surged, even though health experts caution there's insufficient data about their long-term effects and how they work in certain populations.
The FDA said it will next review postmarketing data in its Sentinel system, including health insurance claims and patient health records.
Collection
[
|
...
]